Search Results

Containing any of the words

Only of the type

Awareness Guide for Controlled Drugs Awareness Article

SFDA Chairs Arab Meeting, Discussing Plan to Study 25 Draft of Arab Standards for Medical Devices and Supplies News

SFDA extends period for submitting requests for compliance forms for food transportation during Hajj News

Phase 3, Open/Label Study to evaluate the safety and efficacy of TMC 435 plus Pegylated Interferon alfa-2a and Ripavirin administrated for 12 weeks in treatment-naïve Subjects with Chronic genotype 1 or genotype 4 HCV infection Drug Clinical Trial

(WU2227) NCMDR Weekly Update Medical Report

"phase III, double-blind, placebo-controlled study of post-operative adjuvant concurrent chemo-radiotherapy with or without nimotuzumab for stage III/IV head and neck squamous cell cancer" Clinical Trial

"RAINBOW extension study: an extension study to evaluate the long term efficacy and safety of RAnibizumab compared with laser therapy for the treatment of Infants BOrn prematurely With retinopathy of prematurity" Drug Clinical Trial

“MERS-CoV Infection Treated with a Combination of Lopinavir/Ritonavir and Interferon Beta 1B: A Placebo-Controlled, Double-Blind Randomized Trial (MIRACLE Trial)” Drug Clinical Trial

A 24 month, randomized, controlled, study to evaluate the efficacy and safety of concentration-controlled everolimus plus reduced tacrolimus compared to standard tacrolimus in recipients of living donor liver transplants Drug Clinical Trial

A 2-treatment period, randomized, placebo-controlled, multicenter parallel-group study to assess the safety of QAW039 when added to existing asthma therapy in GINA steps 3, 4 and 5 patients with uncontrolled asthma Drug Clinical Trial